Form 8-K - Current report:
SEC Accession No. 0001362310-09-006030
Filing Date
2009-04-29
Accepted
2009-04-29 13:09:04
Documents
3
Period of Report
2009-04-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c84431e8vk.htm 8-K 9649
2 EXHIBIT 99.1 c84431exv99w1.htm EX-99.1 14575
3 GRAPHIC c84431p8443101.jpg GRAPHIC 10950
  Complete submission text file 0001362310-09-006030.txt   41063
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 09778276
SIC: 2835 In Vitro & In Vivo Diagnostic Substances